“Cool It”: Therapeutic Hypothermia for Recovery of Neurologic Function in High Risk Patients Following Cardiac Arrest Leah A. Swanson, Kalie M. Edelstein, William M. Parham, Jon S. Hokanson, Richard F. Shronts, Barbara T. Unger, Wendy B. George, Ivan J. Chavez, Timothy D. Henry, Michael R. Mooney Minneapolis Heart Institute Foundation Abbott Northwestern Hospital March 29, 2009
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
“Cool It”: Therapeutic Hypothermia for Recovery of Neurologic Function in
High Risk Patients Following Cardiac Arrest
Leah A. Swanson, Kalie M. Edelstein, William M. Parham, Jon S. Hokanson, Richard F. Shronts, Barbara T. Unger, Wendy B. George,
Ivan J. Chavez, Timothy D. Henry, Michael R. Mooney
Minneapolis Heart Institute FoundationAbbott Northwestern Hospital
March 29, 2009
Leah Swanson
The following relationships exist related to this presentation:
No relationships to disclose
Presenter Disclosure Information
Cardiac Arrest
• Out-of-hospital cardiac arrest (OOHCA) • 295,000 people annually in the US• 7.9% median survival rate• Anoxic encephalopathy and neurologic deficits• Therapeutic hypothermia (TH) clinical trials• ILCOR recommendation for TH after resuscitation
Lloyd-Jones D, Adams R, Carnethon M et al. Heart disease and stroke statistics-2009 update. Circulation 2009;119:e21-e181.
Hypothermia History
• 1950s - cardiac and neurologic surgeries
• Late 1950s - after cardiac arrest uncertain benefits
difficulties with implementation
• 1990s - studies in animal models histological benefits
functional benefits
• 2002 - randomized clinical trials of TH
Mechanisms
ischemia
glutamate release
oxygen-free radicals
calcium shifts
mitochondrial dysfunction
reperfusion
excitotoxicity
inflammatory cascades
cell death
blood brain barrier disruption & cerebral
edema
hypothermia
lower metabolic rate
less oxygen consumption
Geocadin RG, Koenig MA, Jia X et al. Management of brain injury after resuscitation from cardiac arrest. Neurol Clin. 2008;22:487-506.
HACA Study Group
• Randomized trial 2002 -hypothermia vs normothermia
• Methods Inclusion - OOHCA due to VF Exclusion – cardiogenic shock
• Hypothermia group 32°C - 34°C cooled for 24 hrs rewarming over 8 hrs
The Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002;346:549-556.
Cooling• no prehospital cooling• mattress cooling device• target temp• ice packs after 4 hrs
Cooling• target temp – as soon as
possible• ice packs in the field,
referring hospital, or in transfer
• Arctic Sun® cooling device
Shivering Prevention
• Pancuronium
• IV bolus every two hrs
Shivering Prevention
• Atracurium
• Infusion - TOF monitoring
“Cool It” vs. HACA Cooling
0
100
200
300
400
500
600
700
800
Tim
e (
min
ute
s)
HACA n=136 "Cool It" n=103
ROSC toTarget Temp
Arctic Sun toTarget Temp
ROSC toArctic Sun
720
309relative hazard
estimate = 1.25
(for 1 hr delay to TH)
Summary
• “Cool It” protocol applied TH to high risk patients cardiogenic shock PEA & asystole
• “Cool It” TH enhanced survival in HACA criteria patients
• “Cool It” TH preserved neurologic and functional status in a broader patient population
• “Cool It” survivors discharged with higher neurologic outcomes
• “Cool It” patients cooled to target temperature in less time
Conclusions• OOHCA is a significant health issue • TH is a markedly underutilized treatment• “Cool It” TH program
high survival rate high quality of life and cognitive and functional abilities
• “Cool It” TH - early & organized treatment standardized protocols outstate education rapid & early initiation of TH multidisciplinary team data collection and feedback
• TH can effectively be applied to a higher risk patient population than previously examined
• Neuroprotective adjunct to regional STEMI programs